Welcome to our dedicated page for XWELL news (Ticker: XWEL), a resource for investors and traders seeking the latest updates and insights on XWELL stock.
XWELL Inc. (Nasdaq: XWEL) operates at the intersection of travel wellness and biosecurity, offering premium spa services and health solutions through brands like XpresSpa® and XpresTest®. This page serves as the definitive source for official company announcements and market-moving developments.
Investors and industry observers will find curated press releases covering operational milestones, including airport spa expansions, biosecurity partnerships, and service innovations. Our repository ensures timely access to earnings reports, leadership updates, and strategic initiatives shaping this health and wellness leader.
All content undergoes strict verification to maintain accuracy and compliance with financial disclosure standards. For ongoing monitoring of XWELL's progress in redefining travel health experiences, bookmark this page and check regularly for updates.
XWELL introduces new esthetic facial services at its Naples Wax Center flagship in Naples, FL, expanding its service offerings with advanced treatments. The new services include the Microderm Infusion Facial, LightStim Invigorating Light Facial, and Classic Refreshing Facial. These treatments aim to enhance skincare by utilizing innovative technologies like DiamondGlow and LED light therapy. XWELL's CEO, Scott Milford, emphasizes the goal to exceed customer expectations and boost revenue through these high-margin services. Additionally, curated retail products from SkinMedica and PCA Skin will be available. This initiative aligns with XWELL’s strategy to grow its out-of-airport portfolio and tech-forward initiatives.
XWELL announced the introduction of the Ceragem V6 Therapeutic Thermal Massager at select XpresSpa locations starting in Q2 2024. This FDA-cleared Class II medical device aims to enhance blood circulation, relieve muscle and joint discomfort, and offer muscle relaxation. The new service will be first launched at Salt Lake City International Airport on May 22, 2024, with subsequent launches at Philadelphia and Orlando airports. XWELL's CEO, Scott Milford, states that this integration supports their strategy to increase revenue and retail traffic cost-effectively. The partnership with Ceragem International is part of XWELL's broader tech-forward initiatives, including IV hydration drip therapies and robotic manicures, solidifying its position in travel wellness.
XWELL, an authority in wellness solutions, reported its first quarter 2024 financial results. The company saw a 24% revenue growth to $8.7 million compared to the same quarter in 2023. Total cost of sales decreased by 7%, and general and administrative expenses were cut by 47%, leading to a 62% reduction in operating loss, now at $2.4 million. XWELL continued to enhance its business model by expanding its CDC Traveler-based Genomic Surveillance Program to Miami and Chicago airports.
Additionally, the company signed leases for new Naples Wax Center locations in Florida and confirmed the opening of an XpresSpa at Penn Station in New York. XWELL also introduced new tech-forward wellness services at its airport locations, including IV hydration therapy. Overall, XWELL aims to return to profitability by focusing on strategic priorities and expanding its wellness portfolio.
XWELL, Inc. (Nasdaq: XWEL) introduces IV hydration drip therapy at its Miami International Airport location in partnership with Revitalize IV Lounge. The therapy aims to deliver essential nutrients directly into the bloodstream, boosting energy levels and aiding recovery from jet lag and illness. The service offers four options starting at $220 per session, with potential for revenue growth and expansion to other markets.